KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bausch Health Companies (BHC) Tax Provisions (2016 - 2025)

Bausch Health Companies (BHC) has disclosed Tax Provisions for 17 consecutive years, with $159.0 million as the latest value for Q4 2025.

  • Quarterly Tax Provisions rose 43.24% to $159.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $247.0 million through Dec 2025, up 3.35% year-over-year, with the annual reading at $247.0 million for FY2025, 3.35% up from the prior year.
  • Tax Provisions hit $159.0 million in Q4 2025 for Bausch Health Companies, up from $37.0 million in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $159.0 million in Q4 2025 to a low of -$77.0 million in Q2 2021.
  • Historically, Tax Provisions has averaged $35.2 million across 5 years, with a median of $38.0 million in 2025.
  • Biggest five-year swings in Tax Provisions: tumbled 200.0% in 2022 and later skyrocketed 556.25% in 2023.
  • Year by year, Tax Provisions stood at -$51.0 million in 2021, then soared by 203.92% to $53.0 million in 2022, then dropped by 24.53% to $40.0 million in 2023, then soared by 177.5% to $111.0 million in 2024, then soared by 43.24% to $159.0 million in 2025.
  • Business Quant data shows Tax Provisions for BHC at $159.0 million in Q4 2025, $37.0 million in Q3 2025, and $12.0 million in Q2 2025.